Publicatie

Publicatie datum

Varicella zoster virus (VZV) infection.

Lier, E.A. van, Suijkerbuijk, A.W.M., Nielen, M., Jochemsen, P., Luytjes, W., Melker, H.E. de. Varicella zoster virus (VZV) infection. In: Alebeek, R. van, Benschop, K., Benthem, B. van, Brinnendijk, R. van, Bogaards, J.A., Bootsma, H.J., Brinkman, I., Bruijning-Verhagen, P., Buisman, A., Cremer, J., Donken, R., Duizer, E., Els, C.A.C.M. van, Ende, A. van der, Friesema, I.H.M., Gent, M. van, Gier, B. de, Gouma, S., Heiningen, F. van, Hoek, W. van der, Hofstraat, S., Hooiveld, M., Hulshof, K., Janga-Jansen, A., Jochemsen, P., Kaaijk, P., Kassteele, J. van de, Kasteren, P.B van, Kemmeren, J.M., Kerkhof, H. van den, King, A.J., Klis, F.R.M. van der, Knol, M.J., Korthals-Altes, H., Lehmann, B., Lier, E.A. van, Luinstra-Passchier, M., Luytjes, W., Maas, N.A.T. van der, Mangen, M.J.J., McDonald, S.A., Meijer, A., Melker, H.E. de, Mollema, L., Monge, S., Nielen, M., Nottermans, D.W., Pasmans, H., Pinelli, E., Prettner, R., Qendri, V., Reubsaet, F.A.G., Romijnders, K., Rots, N.Y., Ruijs, W.L.M., Schurink-van 't Klooster, T.M., Slobbe, J. van, Suijkerbuijk, A.W.M., Teirlinck, A.C., Veldhuizen, I.K., Vennema, H., Verberk, J.D.M., Vos, R.A., Weele, P. van der, Woestenberg, P.J., Woudenberg, T. The National Immunisation Programme in the Netherlands : surveillance and developments in 2016-2017. Bilthoven: RIVM, 2017. 186-196
• The VZV epidemiology (incidence of GP consultations, hospitalisations and deaths) is comparable to previous years.
• For the prevention of herpes zoster (HZ), HZ/su (or Shingrix®) might be a promising alternative for Zostavax® due to the higher sustained vaccine efficacy. It is now being submitted for regulatory approval in the USA, Canada, Japan and Europe.